CYP Alleles TDM |
mutations in certain ethnic populations |
Unfinished |
2013-04-10 |
astephens5 |
16 |
0 |
edit |
|
PDA 3 - Parkinson's |
PDA 3 - Exam 2 |
Unfinished |
2013-03-28 |
astephens5 |
28 |
0 |
edit |
|
PDA 3 - Schizo |
PDA 3 - Exam 2 |
Unfinished |
2013-03-27 |
astephens5 |
64 |
0 |
edit |
|
PDA 3 - Depression |
PDA 3 - Exam 2 |
Unfinished |
2013-03-28 |
astephens5 |
68 |
0 |
edit |
|
PDA 3 - Exam 1 |
PDA 3 - Exam 1 |
Unfinished |
2013-02-21 |
astephens5 |
63 |
0 |
edit |
|
PDA 1 GI Drugs |
GI Drugs Mechanisms of Action |
Pharmacology |
2012-04-06 |
astephens5 |
28 |
0 |
edit |
|
PDA 1 Diabetes Drugs |
Diabetes Drug Mechanisms |
Pharmacology |
2014-08-29 |
astephens5 |
20 |
1 |
edit |
|
Diabete Drug Classes |
Diabetes Drug Classes |
Pharmacology |
2012-04-10 |
astephens5 |
24 |
0 |
edit |
|
GI Drug Classes |
GI Drug Classes |
Pharmacology |
2012-04-10 |
astephens5 |
32 |
0 |
edit |
|
Top 200 Drugs |
part two BPSA final |
Unfinished |
2012-05-07 |
astephens5 |
56 |
0 |
edit |
|
PDA II - Classes/MoA |
Exam 1 |
Pharmacology |
2012-09-21 |
astephens5 |
113 |
0 |
edit |
|
IPSA Top 200 |
Week 4 |
Pharmacology |
2012-09-20 |
astephens5 |
67 |
0 |
edit |
|
PDA II - Exam 2 |
MoA/Classes/random |
Pharmacology |
2012-10-17 |
astephens5 |
159 |
0 |
edit |
|
PDA II - ANS recepto |
PDA II - ANS recepto |
Unfinished |
2012-10-12 |
astephens5 |
42 |
0 |
edit |
|
PDA II Exam 3 - SS 2 |
HTN Autonomics |
Unfinished |
2012-11-27 |
astephens5 |
32 |
0 |
edit |
|
PDA II Exam 3 - SS 3 |
HTN Diuretics |
Unfinished |
2012-11-27 |
astephens5 |
37 |
0 |
edit |
|
PDA II Exam 3 - SS 4 |
HTN Vasodilators |
Unfinished |
2012-11-27 |
astephens5 |
48 |
0 |
edit |
|
PDA II Exam 3 - SS 5 |
HF Patho |
Unfinished |
2012-11-27 |
astephens5 |
21 |
0 |
edit |
|
PDA II Exam 3 - SS 6 |
HF Inotropes |
Unfinished |
2012-11-27 |
astephens5 |
6 |
0 |
edit |
|
PDA II Exam 3 - SS 7 |
HF Diuretics |
Unfinished |
2012-11-27 |
astephens5 |
21 |
0 |
edit |
|
PDA II Exam 4 - SS 1 |
Angina |
Unfinished |
2012-12-04 |
astephens5 |
52 |
0 |
edit |
|
IPSA TOP 200 |
fall 2012 - brand generic |
Unfinished |
2012-12-13 |
astephens5 |
97 |
0 |
edit |
|
PDA II Exam 4 - SS 2 |
Anticoagulants |
Unfinished |
2012-12-11 |
astephens5 |
65 |
0 |
edit |
|
PDA II Exam 4 - SS 3 |
Cholesterol |
Unfinished |
2012-12-12 |
astephens5 |
71 |
0 |
edit |
|
PDA II Exam 4 - SS 4 |
Anti-arrhythmia |
Unfinished |
2012-12-08 |
astephens5 |
80 |
0 |
edit |
|
PDA 3 - Opioids |
Exam 3 - SS 3 |
Unfinished |
2013-04-19 |
astephens5 |
69 |
0 |
edit |
|
PDA 3 - Alzheimer's |
Exam 3 - SS 1 |
Unfinished |
2013-04-21 |
astephens5 |
55 |
0 |
edit |
|
PDA 3 - Anti-Convuls |
Exam 3 - SS 2 |
Unfinished |
2013-04-29 |
astephens5 |
84 |
0 |
edit |
|
PDA 3 - App Suppress |
Exam 3 - SS 4 |
Unfinished |
2013-04-29 |
astephens5 |
43 |
0 |
edit |
|
Thera Diabetes Drugs |
P2 - Johnson |
Unfinished |
2013-05-15 |
astephens5 |
44 |
0 |
edit |
|
Depression |
Therapeutics II |
Unfinished |
2013-12-11 |
astephens5 |
41 |
0 |
edit |
|
Anxiety |
Therapeutics II |
Unfinished |
2013-12-11 |
astephens5 |
27 |
0 |
edit |
|
Insomnia |
Therapeutics II |
Unfinished |
2013-12-11 |
astephens5 |
27 |
0 |
edit |
|
Bipolar |
Therapeutics II |
Unfinished |
2013-12-11 |
astephens5 |
41 |
0 |
edit |
|
Schizo |
Therapeutics II |
Unfinished |
2013-12-11 |
astephens5 |
74 |
0 |
edit |
|
Substance Abuse |
Therapeutics |
Unfinished |
2013-10-10 |
astephens5 |
31 |
0 |
edit |
|
Epilepsy |
Therapeutics |
Unfinished |
2013-10-10 |
astephens5 |
25 |
0 |
edit |
|
Gout |
Therapeutics |
Unfinished |
2013-11-07 |
astephens5 |
50 |
0 |
edit |
|
PUD |
Therapeutics |
Unfinished |
2013-11-07 |
astephens5 |
34 |
0 |
edit |
|
GERD |
Therapeutics |
Unfinished |
2013-11-06 |
astephens5 |
21 |
0 |
edit |
|
IBD |
Therapeutics |
Unfinished |
2013-11-07 |
astephens5 |
41 |
0 |
edit |
|
Liver Disease |
Therapeutics |
Unfinished |
2013-11-07 |
astephens5 |
48 |
0 |
edit |
|
Drug Allergy |
Therapeutics |
Unfinished |
2013-11-07 |
astephens5 |
24 |
0 |
edit |
|
BPH |
Therapeutics II |
Unfinished |
2013-12-03 |
astephens5 |
39 |
0 |
edit |
|
Urinary Incontinence |
Therapeutics II |
Unfinished |
2013-12-04 |
astephens5 |
8 |
0 |
edit |
|
ADHD |
Top 300 Drug Cards |
Unfinished |
2014-01-09 |
astephens5 |
42 |
0 |
edit |
|
Alzheimer's/Dementia |
Top 300 Drug Cards |
Unfinished |
2014-01-09 |
astephens5 |
21 |
0 |
edit |
|
Analgesics |
Top 300 Drug Cards |
Unfinished |
2014-01-09 |
astephens5 |
16 |
0 |
edit |
|
Bugs and Drugs |
Therapeutics III |
Unfinished |
2014-03-07 |
astephens5 |
82 |
0 |
edit |
|
HIV/AIDS, OI, Fungal |
Therapeutics III - Eastman |
Unfinished |
2014-03-07 |
astephens5 |
116 |
0 |
edit |
|
UTI/STI/Hepatitis |
Therapeutics III - Eastman |
Unfinished |
2014-03-07 |
astephens5 |
146 |
0 |
edit |
|
Critical Care |
Therapeutics III - Eastman |
Unfinished |
2021-07-02 |
astephens5 |
63 |
1 |
edit |
|
Pneumonia |
Therapeutics III - Miesner |
Unfinished |
2014-03-10 |
astephens5 |
62 |
0 |
edit |
|
Tuberculosis |
Therapeutics III - Miesner |
Unfinished |
2014-03-10 |
astephens5 |
39 |
0 |
edit |
|
Toxicity - Antidotes |
Therapeutics III - Miesner |
Unfinished |
2014-03-31 |
astephens5 |
18 |
0 |
edit |
|
Pneumonia IMPT |
Therapeutics III - Miesner |
Unfinished |
2014-04-02 |
astephens5 |
10 |
0 |
edit |
|
HPI |
HPI |
Unfinished |
2014-05-01 |
astephens5 |
34 |
0 |
edit |
|
HIV Brand/Generic |
HIV Brand/Generic |
Unfinished |
2015-04-19 |
astephens5 |
26 |
0 |
edit |
|
Herbals |
Indications and Warnings |
Unfinished |
2015-06-25 |
astephens5 |
45 |
0 |
edit |
|
Vitamins |
Names |
Unfinished |
2015-06-25 |
astephens5 |
11 |
0 |
edit |
|
Supplementation |
Recommended supplements for certain populations and drug therapy |
Unfinished |
2015-06-24 |
astephens5 |
12 |
0 |
edit |
|
Supplementation |
Recommended for patients with certain conditions |
Unfinished |
2015-06-24 |
astephens5 |
12 |
0 |
edit |
|
Top Rx Brand-Generic |
From Rx Prep |
Unfinished |
2017-08-09 |
astephens5 |
243 |
1 |
edit |
|
Tox & Antidotes |
RxPrep |
Unfinished |
2015-07-12 |
astephens5 |
29 |
0 |
edit |
|
MO Permits |
MPJE |
Unfinished |
2019-09-07 |
astephens5 |
16 |
1 |
edit |
|
MO Control Substance |
MPJE |
Unfinished |
2019-09-07 |
astephens5 |
62 |
1 |
edit |
|